These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22728894)

  • 1. Current concepts in glucocorticoid resistance.
    Yang N; Ray DW; Matthews LC
    Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
    Ingawale DK; Mandlik SK; Patel SS
    J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of glucocorticoid resistance in multiple sclerosis].
    Rzazewska-Makosa B
    Postepy Hig Med Dosw (Online); 2005 Sep; 59():457-63. PubMed ID: 16177666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
    Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid resistance as a major drive in sepsis pathology.
    Dendoncker K; Libert C
    Cytokine Growth Factor Rev; 2017 Jun; 35():85-96. PubMed ID: 28479044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
    Hapgood JP; Avenant C; Moliki JM
    Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation.
    Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG
    Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
    De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
    World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory mechanisms of glucocorticoids.
    Barnes PJ
    Biochem Soc Trans; 1995 Nov; 23(4):940-5. PubMed ID: 8654871
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness.
    Wikström AC
    J Endocrinol; 2003 Sep; 178(3):331-7. PubMed ID: 12967326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized and tissue specific glucocorticoid resistance.
    Martins CS; de Castro M
    Mol Cell Endocrinol; 2021 Jun; 530():111277. PubMed ID: 33864884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid resistance in asthma: Cellular and molecular mechanisms.
    Caramori G; Nucera F; Mumby S; Lo Bello F; Adcock IM
    Mol Aspects Med; 2022 Jun; 85():100969. PubMed ID: 34090658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma].
    Panek M; Pietras T; Kupryś-Lipińska I; Górski P; Kuna P; Szemraj J
    Postepy Biochem; 2010; 56(4):373-82. PubMed ID: 21473041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
    Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
    J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional proteomics for the characterization of impaired cellular responses to glucocorticoids in asthma.
    Pazdrak K; Kurosky A
    Adv Exp Med Biol; 2014; 795():255-70. PubMed ID: 24162914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
    Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
    Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.